Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
EMBO Rep ; 24(7): e56783, 2023 Jul 05.
Article in English | MEDLINE | ID: mdl-37158562

ABSTRACT

Members of the polycystin family (PKD2 and PKD2L1) of transient receptor potential (TRP) channels conduct Ca2+ and depolarizing monovalent cations. Variants in PKD2 cause autosomal dominant polycystic kidney disease (ADPKD) in humans, whereas loss of PKD2L1 expression causes seizure susceptibility in mice. Understanding structural and functional regulation of these channels will provide the basis for interpreting their molecular dysregulation in disease states. However, the complete structures of polycystins are unresolved, as are the conformational changes regulating their conductive states. To provide a holistic understanding of the polycystin gating cycle, we use computational prediction tools to model missing PKD2L1 structural motifs and evaluate more than 150 mutations in an unbiased mutagenic functional screen of the entire pore module. Our results provide an energetic landscape of the polycystin pore, which enumerates gating sensitive sites and interactions required for opening, inactivation, and subsequent desensitization. These findings identify the external pore helices and specific cross-domain interactions as critical structural regulators controlling the polycystin ion channel conductive and nonconductive states.


Subject(s)
TRPP Cation Channels , Transient Receptor Potential Channels , Humans , Mice , Animals , TRPP Cation Channels/chemistry , Signal Transduction , Ion Transport , Transient Receptor Potential Channels/genetics , Mutation , Receptors, Cell Surface/metabolism , Calcium Channels/metabolism
2.
Proc Natl Acad Sci U S A ; 120(22): e2219686120, 2023 05 30.
Article in English | MEDLINE | ID: mdl-37216541

ABSTRACT

Polycystins (PKD2, PKD2L1, and PKD2L2) are members of the transient receptor potential family, which form ciliary ion channels. Most notably, PKD2 dysregulation in the kidney nephron cilia is associated with polycystic kidney disease, but the function of PKD2L1 in neurons is undefined. In this report, we develop animal models to track the expression and subcellular localization of PKD2L1 in the brain. We discover that PKD2L1 localizes and functions as a Ca2+ channel in the primary cilia of hippocampal neurons that apically radiate from the soma. Loss of PKD2L1 expression ablates primary ciliary maturation and attenuates neuronal high-frequency excitability, which precipitates seizure susceptibility and autism spectrum disorder-like behavior in mice. The disproportionate impairment of interneuron excitability suggests that circuit disinhibition underlies the neurophenotypic features of these mice. Our results identify PKD2L1 channels as regulators of hippocampal excitability and the neuronal primary cilia as organelle mediators of brain electrical signaling.


Subject(s)
Autism Spectrum Disorder , Cilia , Mice , Animals , Cilia/metabolism , Autism Spectrum Disorder/metabolism , TRPP Cation Channels/genetics , TRPP Cation Channels/metabolism , Neurons/metabolism , Hippocampus/metabolism , Receptors, Cell Surface/metabolism , Calcium Channels/metabolism
3.
Cell Rep ; 40(8): 111248, 2022 08 23.
Article in English | MEDLINE | ID: mdl-36001977

ABSTRACT

Voltage-gated sodium channels (NaV) in nociceptive neurons initiate action potentials required for transmission of aberrant painful stimuli observed in osteoarthritis (OA). Targeting NaV subtypes with drugs to produce analgesic effects for OA pain management is a developing therapeutic area. Previously, we determined the receptor site for the tamoxifen analog N-desmethyltamoxifen (ND-Tam) within a prokaryotic NaV. Here, we report the pharmacology of ND-Tam against eukaryotic NaVs natively expressed in nociceptive neurons. ND-Tam and analogs occupy two conserved intracellular receptor sites in domains II and IV of NaV1.7 to block ion entry using a "bind and plug" mechanism. We find that ND-Tam inhibition of the sodium current is state dependent, conferring a potent frequency- and voltage-dependent block of hyperexcitable nociceptive neuron action potentials implicated in OA pain. When evaluated using a mouse OA pain model, ND-Tam has long-lasting efficacy, which supports the potential of repurposing ND-Tam analogs as NaV antagonists for OA pain management.


Subject(s)
Tamoxifen , Voltage-Gated Sodium Channels , Action Potentials , Ganglia, Spinal , Humans , Nociceptors , Pain/drug therapy , Tamoxifen/pharmacology , Tamoxifen/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...